Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (341-350 of 491) with videos related to

Pageof 50
Sort By:
Journal of Hepatology|May 4, 2023
TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysisHélène Larrue, Gennaro D'Amico, Pol Olivas, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2022
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver diseaseLorenz Balcar, Bernhard Scheiner, Markus Urheu, et al.
Plos One|February 4, 2015
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfectionChristian Jansen, Thomas Reiberger, Jia Huang, et al.
Biomedicines|January 13, 2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH ModelPhilipp Schwabl, Eva Hambruch, Grant R Budas, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
Wiener Klinische Wochenschrift|December 3, 2020
Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in AustriaNikolaus Pfisterer, Caroline Schmidbauer, Florian Riedl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 23, 2026
The Link of Portal-Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in CirrhosisNikolaus Pfisterer, Irina Lie-Ungurean, Jurij Maurer, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2023
Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosisGeorg Semmler, Bernhard Scheiner, Lorenz Balcar, et al.
European Radiology Experimental|August 12, 2025
MRI-derived quantification of hepatic vessel-to-volume ratios in chronic liver disease using a deep learning approachAlexander Herold, Daniel Sobotka, Lucian Beer, et al.
AIDS (London, England)|July 10, 2013
The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patientsMattias Mandorfer, Karin Neukam, Thomas Reiberger, et al.
Pageof 50

Showing results (341-350 of 491) with videos related to

Sort By:
Pageof 50
Journal of Hepatology|May 4, 2023
TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysisHélène Larrue, Gennaro D'Amico, Pol Olivas, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2022
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver diseaseLorenz Balcar, Bernhard Scheiner, Markus Urheu, et al.
Plos One|February 4, 2015
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfectionChristian Jansen, Thomas Reiberger, Jia Huang, et al.
Biomedicines|January 13, 2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH ModelPhilipp Schwabl, Eva Hambruch, Grant R Budas, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
Wiener Klinische Wochenschrift|December 3, 2020
Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in AustriaNikolaus Pfisterer, Caroline Schmidbauer, Florian Riedl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 23, 2026
The Link of Portal-Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in CirrhosisNikolaus Pfisterer, Irina Lie-Ungurean, Jurij Maurer, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2023
Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosisGeorg Semmler, Bernhard Scheiner, Lorenz Balcar, et al.
European Radiology Experimental|August 12, 2025
MRI-derived quantification of hepatic vessel-to-volume ratios in chronic liver disease using a deep learning approachAlexander Herold, Daniel Sobotka, Lucian Beer, et al.
AIDS (London, England)|July 10, 2013
The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patientsMattias Mandorfer, Karin Neukam, Thomas Reiberger, et al.
Pageof 50